Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: May 9, 2024
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the first quarter ended March 31, 2024.
Read more at globenewswire.com
